Filter
2034
Text search:
mass
drug
Featured
Recommendations
195
New Publications
548
Language
Document type
No document type
1120
Studies & Reports
364
Guidelines
264
Manuals
112
Strategic & Response Plan
99
Fact sheets
28
Training Material
27
Situation Updates
8
Infographics
6
Resource Platforms
3
Online Courses
2
Brochures
1
Countries / Regions
India
139
Global
98
Kenya
63
Ethiopia
60
Uganda
58
Tanzania
45
South Africa
43
Nigeria
40
Liberia
39
Nepal
38
Bangladesh
38
Western and Central Europe
38
Sierra Leone
37
Zambia
37
Malawi
35
Rwanda
33
Ghana
31
Myanmar / Burma
29
Philippines
26
Latin America and the Carribbean
26
Namibia
24
Africa
24
Ukraine
21
Cambodia
20
Eastern Europe
19
Zimbabwe
16
South–East Asia Region
16
Asia
13
Senegal
12
Indonesia
12
Mozambique
12
Syria
11
Lesotho
11
Congo, Democratic Republic of
10
Russia
10
Eswatini/ Swaziland
9
Botswana
9
West and Central Africa
9
Brazil
7
East and Southern Africa
7
Pakistan
6
South Sudan
6
Thailand
6
Vietnam
6
Guinea
5
Haiti
5
Germany
5
Eastern Europe and Central Asia
5
Laos
5
Burkina Faso
4
USA
4
Afghanistan
4
China
4
Sudan
4
Peru
4
Middle East and North Africa
4
Western Pacific Region
4
Timor Leste/ East Timor
4
Cameroon
3
Somalia
3
Iraq
3
Turkey
3
Colombia
3
El Salvador
3
Sri Lanka
3
Yemen
3
Bhutan
3
Venezuela
3
Iran
3
Georgia
3
North America
3
United Kingdom
3
Mali
2
Saudi Arabia
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Argentina
2
Bolivia
2
Libya
2
Madagascar
2
Mexico
2
Albania
2
Tajikistan
2
Morocco
1
Egypt
1
Chad
1
Gambia
1
North Macedonia
1
Switzerland
1
Honduras
1
Ecuador
1
Greece
1
Angola
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Armenia
1
Mongolia
1
Southern Africa
1
Canada
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
890
Clinical Guidelines
185
Public Health
129
Key Resources
73
Women & Child Health
61
Capacity Building
24
Pharmacy & Technologies
17
Annual Report MEDBOX
1
Toolboxes
NTDs
179
TB
144
HIV
129
Mental Health
118
COVID-19
92
AMR
71
NCDs
69
Malaria
61
Pharmacy
47
Planetary Health
40
Rapid Response
35
Caregiver
35
Conflict
33
Refugee
31
Ebola & Marburg
27
Global Health Education
26
Cholera
15
Natural Hazards
12
Specific Hazards
12
2.0 Rapid Response
12
Health Financing Toolbox
11
Disability
9
Social Ethics
7
Zika
5
Polio
4
Fragile Beginnings. The Fragile Beginnings series examines the growing body of research on the unique vulnerabilities of children: in utero and at birth, during infancy and childhood and throughout adolescence. Its purpose is to enable evidence-based advocacy and action on children’s environmental
...
This policy brief presents a summary of current evidence on vulnerability to TB and proposes interventions for equitable, person-centred, and human rights-based TB prevention and care. It aligns with WHO policies and guidance on TB prevention and screening, management of TB and comorbidities, access
...
The Rwanda Malaria Strategic Plan 2020–2024 outlines Rwanda’s national strategy to reduce malaria morbidity and mortality by at least 50% compared to 2019 levels. The vision is a malaria-free Rwanda contributing to socioeconomic development.
The plan includes strengthening prevention through lo
...
National tuberculosis (TB) prevalence surveys provide a nationally representative measurement of the burden of TB disease in the population, at a given point in time. Repeat surveys allow assessment of trends and tracking of progress towards national and global targets for reductions in TB disease b
...
The 2024 edition reviews more than 50 health-related indicators from the Sustainable Development Goals and WHO’s Thirteenth General Programme of Work. It also highlights the findings from the Global health estimates 2021, notably the impact of the COVID-19 pandemic on life expectancy and healthy l
...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness
...
The overall objective of this approach is to accelerate efforts toward malaria elimination by increasing
access to early diagnosis and treatment. The specific objectives are to: Minimize the barriers that the population faces in accessing timely, quality diagnosis and treatment. Reduce the time bet
...
2023 was another year of significant progress in the fight against HIV, tuberculosis (TB) and malaria. In countries where the Global
Fund invests, there has been a full recovery from the disruptive impact of the COVID-19 pandemic. The results we have achieved in the last year build on our extraord
...
The 2022 report reviews the global malaria diagnostics market and technological landscape to support Unitaid’s 2023–2027 strategy for quality malaria case management. The report highlights the stalled progress of malaria control efforts, the gaps in access to diagnostics and the public health im
...
Non-Communicable Diseases (NCDs) have emerged as conditions of great public health concern in Kenya accounting for 39% of deaths annually. The Ministry of Health through the Department of Non-Communicable Diseases has adopted the vision of achieving a nation free from preventable burden of NCDs. Fur
...
Drawing on the World Health Organization’s package of NCD best buys, the report demonstrates how these evidence-based measures can help countries reduce premature deaths, strengthen health systems, and advance progress towards the Sustainable Development Goals. It provides policymakers, donors, ad
...
These guidelines, produced in 2022 by the Uganda Ministry of Health, provide guidance on the diagnosis of HIV, the care of people living with HIV, and the use of antiretroviral drugs for treating and preventing HIV infection, including injectable cabotegravir and the dapivirine vaginal ring.
